AI Verdict
EW has stronger fundamentals based on our AI analysis.
ABBV vs EW Fundamental Comparison
| Metric | ABBV | EW |
|---|---|---|
| Revenue | $61.2B | $6.1B |
| Net Income | $4.2B | $1.1B |
| Net Margin | 6.9% | 17.7% |
| ROE | N/A | 10.4% |
| ROA | 3.2% | 7.8% |
| Current Ratio | 0.67x | 3.72x |
| Debt/Equity | N/A | 0.06x |
| EPS | $2.36 | $1.83 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABBV vs EW: Frequently Asked Questions
Is ABBV or EW a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), EW has stronger fundamentals. ABBV is rated HOLD (70% confidence) while EW is rated BUY (85% confidence). This is not investment advice.
How does ABBV compare to EW fundamentally?
AbbVie Inc. has ROE of N/A vs Edwards Lifesciences Corp's 10.4%. Net margins are 6.9% vs 17.7% respectively.
Which stock pays higher dividends, ABBV or EW?
ABBV has a dividend yield of N/A or no dividend while EW has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABBV or EW for long term?
For long-term investing, consider that ABBV has HOLD rating with 70% confidence, while EW has BUY rating with 85% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABBV vs EW?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABBV vs EW, the AI consensus favors EW based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.